Background Outpatient cardiac rehabilitation (CR) is a promising tool for improving functional outcome in stroke survivors, however, evidence for improving emotional health is limited. We aimed to clarify the effects of outpatient CR following in-hospital stroke rehabilitation on health-related quality of life (HRQOL) and motor function.

Methods Patients with acute ischemic stroke or transient ischemic attack discharged directly home were recruited, and 128 patients (male, 92, mean age,73.5 years) who fulfilled criteria for insurance coverage of CR were divided into the CR (+) group (n=46) and CR (−) group (n=82). All patients underwent in-hospital stroke rehabilitation, and within 2 months after stroke onset, patients in the CR (+) group started a 3-month outpatient CR program of supervised outpatient sessions (1-3 times/week). Changes of motor function and HRQOL assessed by the short form-36 version 2 (SF-36) from discharge to 3 months post-discharge were compared between the two groups.

Results Twenty-six patients in the CR (+) group completed the program and 66 patients in the CR (−) group were followed up at a 3-month examination. Least-square mean changes in 6-minute walk distance and isometric knee extension muscle strength were significantly higher in the CR (+) group than the CR (−) group (52.6 vs. 16.3 m; 10.1 vs. 3.50 kgf/kg). Improvement of HRQOL at 3 months was not observed in the CR (+) group.

Conclusions Outpatient CR followed by in-hospital stroke rehabilitation within 2 months after stroke onset improved exercise tolerance and functional strength but not HRQOL after completion of CR.

The authors have declared no competing interest.

the UMIN Clinical Trials Registry (ID: UMIN000024655)

This study was supported by the Intramural Research Fund of the National Cerebral and Cardiovascular Center (21-1-4) and Grants-in-Aid for Scientific Research in Japan (21K11332).

I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.

Yes

The details of the IRB/oversight body that provided approval or exemption for the research described are given below:

The present study was a single-center, retrospective, observational study approved by the Ethics Committee of the National Cerebral and Cardiovascular Center (M28-063-15).

I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.

Yes

I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).

Yes

I have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.

Yes

All data are available from the corresponding author upon reasonable request.